Vaderis Therapeutics AG
@vaderis.com
Vaderis is a science-driven, patient-focused biotech with a singular aim: to be the first to bring breakthrough therapies to people with HHT and other rare vascular diseases. Our work is guided by deep biological insight, a relentless commitment to rigorous science, impeccable execution and an unwavering belief that meaningful change is possible. We advance with purpose, inspired by the patients who drive us forward and by the promise of what has yet to be achieved. Pioneering care for people with unmet needs.
Vaderis Therapeutics AG's Company Logos
Vaderis Therapeutics AG's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0878BC
Lochmara
8, 120, 188
203, 92, 38
96, 36, 0, 26
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#343333
Mine Shaft
52, 51, 51
0, 1, 20
0, 2, 2, 80
About Vaderis Therapeutics AG
Vaderis is a clinical stage biotechnology company singularly dedicated to the treatment of rare and orphan diseases caused by Vascular Malformations. With the mission to provide innovative solutions, Vaderis aims to become the pioneering company in developing a medicine for Hereditary Haemorrhagic Telangiectasia (HHT). At the core of their groundbreaking work lies VAD044, an oral medicine currently under development.
If successful, VAD044 has the potential to alleviate HHT symptoms while also reducing the occurrence of new lesions, effectively modifying the disease's progression. Committed to excellence, Vaderis boasts a highly skilled and knowledgeable team of experts. Led by Nicholas Benedict, Pierre Saint-Mezard, Rossella Medori, Damien Picard, and Hedvika Lazar, their remarkable leadership ensures a cutting-edge approach to tackling these challenging diseases.
Vaderis partners with leading organizations, including Vaderis Therapeutics AG, to foster innovation and drive progress in the field. Through scientific collaborations, investments, and strategic partnerships, Vaderis continues to advance their robust pipeline of novel treatments. Discover more about Vaderis, their visionary initiatives, and groundbreaking research by visiting their website.
Don't miss the opportunity to join their mission in revolutionizing the treatment of rare diseases caused by Vascular Malformations
Brand industry
Science and Education
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
